China Leuprorelin Market, 2010-2019 - Market Research, Insights, Outlook, OVerview Report: ResearchMoz
Originally developed by Takeda Pharmaceutical Co., Ltd, leuprorelin is a polypeptide used to treat prostate cancer and so on. Leuprorelin can inhibit pituitary gland and release gonadotropin Leuprolide acts as an agonist at pituitary GnRH receptors, leading to hypogonadism and thus a dramatic reduction in estradiol and testosterone levels in both sexes.
View full press release